Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Pediatric Blood & Cancer
|
May 21, 2010
Dying to predict outcome
Laura E Hogan, Elizabeth A Raetz
Leukemia & Lymphoma
|
June 11, 2024
Low-risk relapsed acute lymphoblastic leukemia in children and young adults: what have we learnt and what's next?
Teena Bhatla, Stacy Cooper, Laura E Hogan
Expert Review of Anticancer Therapy
|
June 27, 2017
New targeted therapies for relapsed pediatric acute lymphoblastic leukemia
Joanna Pierro, Laura E Hogan, Teena Bhatla, et al.
Journal of Pediatric Hematology/Oncology
|
September 16, 2014
The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia
Nicholas A Vitanza, Laura E Hogan, Guangxiang Zhang, et al.
Haematologica
|
June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial
Laura E Hogan, Teena Bhatla, Xinxin Xu, et al.
Blood
|
September 17, 2011
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
Laura E Hogan, Julia A Meyer, Jun Yang, et al.
JAMA
|
March 2, 2021
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
Patrick A Brown, Lingyun Ji, Xinxin Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2023
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse
Laura E Hogan, Patrick A Brown, Lingyun Ji, et al.
Nature Genetics
|
February 5, 2013
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
Julia A Meyer, Jinhua Wang, Laura E Hogan, et al.
Blood
|
August 19, 2024
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study
Teena Bhatla, Laura E Hogan, David T Teachey, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Pediatric Blood & Cancer
|
May 21, 2010
Dying to predict outcome
Laura E Hogan, Elizabeth A Raetz
Leukemia & Lymphoma
|
June 11, 2024
Low-risk relapsed acute lymphoblastic leukemia in children and young adults: what have we learnt and what's next?
Teena Bhatla, Stacy Cooper, Laura E Hogan
Expert Review of Anticancer Therapy
|
June 27, 2017
New targeted therapies for relapsed pediatric acute lymphoblastic leukemia
Joanna Pierro, Laura E Hogan, Teena Bhatla, et al.
Journal of Pediatric Hematology/Oncology
|
September 16, 2014
The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia
Nicholas A Vitanza, Laura E Hogan, Guangxiang Zhang, et al.
Haematologica
|
June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial
Laura E Hogan, Teena Bhatla, Xinxin Xu, et al.
Blood
|
September 17, 2011
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
Laura E Hogan, Julia A Meyer, Jun Yang, et al.
JAMA
|
March 2, 2021
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
Patrick A Brown, Lingyun Ji, Xinxin Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2023
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse
Laura E Hogan, Patrick A Brown, Lingyun Ji, et al.
Nature Genetics
|
February 5, 2013
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
Julia A Meyer, Jinhua Wang, Laura E Hogan, et al.
Blood
|
August 19, 2024
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study
Teena Bhatla, Laura E Hogan, David T Teachey, et al.
Page
of 2